These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4839374)

  • 41. [Exchange transfusion as a method of treatment of hepatic coma].
    Boroń P; Modzelewski T
    Dtsch Z Verdau Stoffwechselkr; 1970; 30(1):53-6. PubMed ID: 5501428
    [No Abstract]   [Full Text] [Related]  

  • 42. Hepatic organic anion transport following portacaval shunt in patients with cirrhosis.
    Zsigmond GL; Bodnár A; Karácsonyi S
    Acta Chir Hung; 1984; 25(2):97-106. PubMed ID: 6464621
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Successful use of bromocriptine in the treatment of a patient with chronic portasystemic encephalopathy.
    Morgan MY; Jakobovits A; Elithorn A; James IM; Sherlock S
    N Engl J Med; 1977 Apr; 296(14):793-4. PubMed ID: 576493
    [No Abstract]   [Full Text] [Related]  

  • 44. Immediate and long-term portal hemodynamic consequences of small-diameter H-graft portacaval shunt.
    Zervos EE; Goode SE; Rosemurgy AS
    J Surg Res; 1998 Jan; 74(1):71-5. PubMed ID: 9536977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The physiopathological role of quinolinic acid in the mammalian central nervous system.
    Lombardi G; Carlà V; Moroni F
    Ann Ist Super Sanita; 1988; 24(3):431-6. PubMed ID: 2973276
    [No Abstract]   [Full Text] [Related]  

  • 46. Type-2 hepatorenal syndrome and refractory ascites: role of transjugular intrahepatic portosystemic stent-shunt in eighteen patients with advanced cirrhosis awaiting orthotopic liver transplantation.
    Testino G; Ferro C; Sumberaz A; Messa P; Morelli N; Guadagni B; Ardizzone G; Valente U
    Hepatogastroenterology; 2003; 50(54):1753-5. PubMed ID: 14696397
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Serum concentration of zinc in patients with liver cirrhosis with and without chronic hepatic encephalopathy. Results of a prospective study].
    Garcia-Compean D; Perez-Martinez C; Cuellar JA; Barragan RF; Piñeyro Lopez A
    Gastroenterol Clin Biol; 1994; 18(3):295-6. PubMed ID: 7926452
    [No Abstract]   [Full Text] [Related]  

  • 48. [Extension of indications for portal shunt operation through the management of postoperative liver decompensation with peritoneal dialysis].
    Kraemer HJ
    Munch Med Wochenschr; 1968 Feb; 110(7):406-9. PubMed ID: 5695059
    [No Abstract]   [Full Text] [Related]  

  • 49. [Thrombocytopenia and liver cirrhosis].
    Frick W
    Schweiz Med Wochenschr; 1967 Apr; 97(13):407-13. PubMed ID: 4174227
    [No Abstract]   [Full Text] [Related]  

  • 50. Encephalopathy and portacaval anastomosis.
    Kardel T; Lund Y; Olsen PZ; Möllgaard V; Gammeltoft A
    Scand J Gastroenterol; 1970; 5(8):681-5. PubMed ID: 5485569
    [No Abstract]   [Full Text] [Related]  

  • 51. [Late results of portacaval anastomosis in liver cirrhosis].
    Rapant V; Hauftová D
    Cas Lek Cesk; 1969 Jul; 108(33):969-74. PubMed ID: 5800391
    [No Abstract]   [Full Text] [Related]  

  • 52. Thyroid function tests in non-alcoholic cirrhotic patients with hepatic encephalopathy.
    Güven K; Kelestimur F; Yücesoy M
    Eur J Med; 1993 Feb; 2(2):83-5. PubMed ID: 8258022
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of urease inhibition in hyperammonemia: clinical and experimental studies with acetohydroxamic acid.
    Summerskill WH; Thorsell F; Feinberg JH; Aldrete JS
    Gastroenterology; 1968 Jan; 54(1):20-6. PubMed ID: 5635434
    [No Abstract]   [Full Text] [Related]  

  • 54. Theory and experience behind the use of coagulation tests in diagnosis and prognosis of liver disease.
    Koller F
    Scand J Gastroenterol Suppl; 1973; 19():51-61. PubMed ID: 4515641
    [No Abstract]   [Full Text] [Related]  

  • 55. [Evaluation of 187 troncular portacaval shunts. Statistical analysis of prognosis factors 1. Overall view of the patients and results].
    Leger L; Lenriot JP; Duclos JM; Lemairge G
    J Chir (Paris); 1974; 108(1-2):31-46. PubMed ID: 4548426
    [No Abstract]   [Full Text] [Related]  

  • 56. Three decades of experience with emergency portacaval shunt for acutely bleeding esophageal varices in 400 unselected patients with cirrhosis of the liver.
    Orloff MJ; Orloff MS; Orloff SL; Rambotti M; Girard B
    J Am Coll Surg; 1995 Mar; 180(3):257-72. PubMed ID: 7874335
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis.
    Huber M; Rössle M; Siegerstetter V; Ochs A; Haag K; Kist M; Blum HE
    Hepatogastroenterology; 2001; 48(38):541-4. PubMed ID: 11379349
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Effect of porto-systemic anastomosis on the liver function of patients suffering from liver cirrhosis. Clinical and statistical study].
    Crosti P; Vigo P; Giovannelli C; Mercuriali F
    Recenti Prog Med; 1972 Mar; 52(3):214-42. PubMed ID: 5067691
    [No Abstract]   [Full Text] [Related]  

  • 59. Pig liver perfusion in the treatment of acute hepatic failure.
    Ranek L; Hansen RI; Hilden M; Ramsöe K; Schmidt A; Winkler K; Tygstrup N
    Scand J Gastroenterol Suppl; 1971; 9():161-9. PubMed ID: 5284139
    [No Abstract]   [Full Text] [Related]  

  • 60. [Hepatic encephalopathy after portacaval anastomosis. Retrospective analysis of its occurrence at the clinical and subclinical level].
    Troiani R; Lombardi M; Dell'Amico P; Isoppi E; Vinciguerra G; Pincione F; Ambrogi M; Nicosia F; Sicari A
    Minerva Dietol Gastroenterol; 1985; 31(2):167-74. PubMed ID: 4034023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.